✦ LIBER ✦

Prognosis of intracranial germ cell tumours: Effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16)

✍ Scribed by J. Yoshida; K. Sugita; T. Kobayashi; K. Takakura; N. Shitara; M. Matsutani; R. Tanaka; H. Nagai; H. Yamada; J. Yamashita; Y. Oda; T. Hayakawa; Y. Ushio

Book ID: 105466530
Publisher: Springer Vienna
Year: 1993
Tongue: English
Weight: 614 KB
Volume: 120
Category: Article
ISSN: 0001-6268
DOI: 10.1007/bf02112027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy of germ-cell ovarian tumour

Chemotherapy of germ-cell ovarian tumours: First-line treatment with etoposide, bleomycin and cisplatin or carboplatin

✍ Smales, E.; Peckham, M.J. 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 628 KB

Salvage chemotherapy in refractory germ

Salvage chemotherapy in refractory germ cell tumors with etoposide (vp-16) plus ifosfamide plus high-dose cisplatin. A vihp regimen

✍ M. Ghosn; J. P. Droz; C. Theodore; J. L. Plco; D. Baume; M. Spielmann; M. Ostron 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 1 views

Combined chemotherapy with ifosfamide an

Combined chemotherapy with ifosfamide and cisplatin and with ifosfamide and etoposide (VP-16) in non-small cell carcinoma of the bronchus

✍ Manke, H.G.; Drings, P.; Stiefel, P.; Schmitteckert, H.; Grimm, V.; Kleckow, M. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 372 KB

Treatment of poor prognosis germ cell tu

Treatment of poor prognosis germ cell tumours with high dose cisplatin regimens

✍ R. F. OZOLS 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 633 KB

A meta-analysis of the role of etoposide

A meta-analysis of the role of etoposide (VP16) and cisplatin (CDDP) in small cell lung cancer (SCLC) with a methodology assessment

✍ T. Berghmans; M. Paesmans; C. Mascaux; F. Branle; J.J. Lafitte; F. Lemaître; A.P 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Comparative study of chemotherapy with c

Comparative study of chemotherapy with cisplatin (CDDP) bleomycin (BLEO) and vindesine (VDS) versus CDDP, bleo and VP 16 for the treatment of non small cell lung cancer (NSCLC)

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 88 KB